Bellevue Life Sciences-RTSBLACRPreferred / convertible
13F holders, Q1 2024 (March 31)31holders
1famous investor
$0.15avg. 13F price*
At the end of Q1 2024, 31 institutions reported holding Bellevue Life Sciences-RTS (BLACR) in their 13F filings. The largest holders were Periscope Capital Inc. ($130K), Highbridge Capital Management LLC ($125K) and Polar Asset Management Partners Inc. ($54K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Bellevue Life Sciences-RTS
- CUSIP
- 079174124
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $20K |
| Exits | 0 | $0 |
Ownership 31 holders
| Periscope Capital Inc. | — | No change | 907,000 | $130K |
| Highbridge Capital Management LLC | — | No change | 836,469 | $125K |
| Polar Asset Management Partners Inc. | — | No change | 360,000 | $54K |
| Atw Spac Management LLC | — | No change | 311,040 | $47K |
| JPMorgan Chase & Co. | — | No change | 300,000 | $45K |
| Boothbay Fund Management, LLC | — | No change | 311,040 | $44K |
| Saba Capital Management, L.P. | — | No change | 250,000 | $36K |
| Rivernorth Capital Management, LLC | — | No change | 250,000 | $35K |
| Clear Street LLC | — | Reduce -0.3% | 190,858 | $29K |
| Shaolin Capital Management LLC | — | No change | 190,000 | $28K |
| Exos Asset Management LLC | — | — | 200,000 | $27K |
| Walleye Capital LLC | — | No change | 168,128 | $25K |
| CVI Holdings, LLC | — | No change | 156,176 | $23K |
| D. E. Shaw & Co. | — | No change | 150,000 | $22K |
| Wolverine Asset Management LLC | — | No change | 121,585 | $18K |
| Sea Otter Advisors LLC | — | New | 122,000 | $17K |
| Centiva Capital, LP | — | No change | 100,000 | $15K |
| AQR Arbitrage LLC | — | No change | 100,000 | $15K |
| Walleye Trading LLC | — | No change | 94,572 | $14K |
| Mint Tower Capital Management B.V. | — | No change | 75,000 | $11K |
| Spartan Fund Management Inc. | — | Reduce -56.4% | 69,076 | $10K |
| Schechter Investment Advisors, LLC | — | No change | 46,500 | $6K |
| Gabelli Funds LLC | — | No change | 27,050 | $4K |
| SkyView Investment Advisors, LLC | — | No change | 30,000 | $4K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | — | No change | 20,800 | $3K |
| Bulldog Investors, LLP | — | New | 19,640 | $3K |
| Wealthspring Capital LLC | — | Reduce -27.1% | 16,450 | $2K |
| Flow Traders U.S. LLC | — | Reduce -18.6% | 11,850 | $2K |
| Condor Capital Management | — | No change | 10,400 | $1K |
| Bank of America Corp. | — | No change | 100 | $14 |
| UBS Group AG | — | New | 22 | $3 |
"% of holder's portfolio" is BLACR's weight in each manager's 13F, not the share of Bellevue Life Sciences-RTS the manager owns.